Nomura Holdings Inc. purchased a new stake in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,298 shares of the semiconductor company's stock, valued at approximately $534,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Jones Financial Companies Lllp boosted its holdings in Silicon Laboratories by 44.5% in the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 69 shares during the last quarter. Headlands Technologies LLC purchased a new stake in Silicon Laboratories in the fourth quarter worth approximately $70,000. Venturi Wealth Management LLC boosted its holdings in Silicon Laboratories by 207.0% in the fourth quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company's stock worth $98,000 after purchasing an additional 530 shares during the last quarter. Asset Management One Co. Ltd. purchased a new stake in Silicon Laboratories in the fourth quarter worth approximately $117,000. Finally, KBC Group NV boosted its holdings in Silicon Laboratories by 42.1% in the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company's stock worth $159,000 after purchasing an additional 379 shares during the last quarter.
Analyst Upgrades and Downgrades
SLAB has been the topic of several research reports. Barclays dropped their target price on shares of Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 22nd. Stifel Nicolaus dropped their price target on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating on the stock in a research note on Thursday, April 17th. Needham & Company LLC reiterated a "buy" rating and set a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, May 14th. Susquehanna lifted their price target on shares of Silicon Laboratories from $100.00 to $110.00 and gave the stock a "neutral" rating in a research note on Wednesday, May 14th. Finally, Benchmark reiterated a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a research note on Tuesday. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $126.50.
Get Our Latest Report on SLAB
Insider Activity
In other news, SVP Robert J. Conrad sold 1,172 shares of the firm's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $130.00, for a total transaction of $152,360.00. Following the sale, the senior vice president now directly owns 15,972 shares in the company, valued at $2,076,360. This trade represents a 6.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Christy Wyatt sold 546 shares of the firm's stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $104.45, for a total transaction of $57,029.70. Following the sale, the director now owns 8,492 shares in the company, valued at $886,989.40. The trade was a 6.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,626 shares of company stock worth $1,509,319 in the last three months. Company insiders own 1.60% of the company's stock.
Silicon Laboratories Stock Performance
Shares of Silicon Laboratories stock traded up $3.95 on Tuesday, hitting $125.38. 318,978 shares of the company's stock were exchanged, compared to its average volume of 337,694. The company has a 50-day simple moving average of $108.78 and a 200-day simple moving average of $121.86. The stock has a market capitalization of $4.08 billion, a PE ratio of -21.11 and a beta of 1.36. Silicon Laboratories Inc. has a 1 year low of $82.82 and a 1 year high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The semiconductor company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.01. The firm had revenue of $177.71 million for the quarter, compared to the consensus estimate of $177.48 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The company's revenue was up 67.0% on a year-over-year basis. During the same period last year, the firm earned ($0.92) EPS. On average, analysts expect that Silicon Laboratories Inc. will post -0.97 EPS for the current fiscal year.
Silicon Laboratories Company Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Articles

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report